The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

CORONARY INTERVENTIONS

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

EuroIntervention 2016;12:e224-e234 published online e-edition June 2016. DOI: 10.4244/EIJV12I2A36

1. Hospital Clinico San Carlos/Faculty of Medicine Complutense University, Madrid, Spain; 2. John Radcliffe Hospital, Oxford, United Kingdom; 3. Institute of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, University of Manchester and

Aims: The applicability of the results of the SYNTAX trial comparing percutaneous coronary intervention (PCI) using first-generation drug-eluting stents (DES) with coronary artery bypass

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial